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Abstract
Rationale Previously we demonstrated reduced D2/3 recep-
tor availability in the ventral striatum of hyper-impulsive
rats on the five-choice serial reaction time task (5-CSRTT).
However, the anatomical locus of D2/3 receptor dysfunction
in high impulsive (HI) rats is unknown.
Objective In the present study, we investigated whether D2/3
receptor dysfunction in HI rats is localised to the core or
shell sub-regions of the nucleus accumbens (NAcb).
Methods Rats were selected for low (low impulsive, LI) and
high impulsivity on the 5-CSRTT and implanted with guide
cannulae targeting the NAcb core and shell. The D2/3 recep-
tor agonist quinpirole was locally injected in the NAcb (0.1,
0.3 and 1 μg per infusion) and its effects investigated on the
performance of LI and HI rats on the 5-CSRTT as well as
spontaneous locomotor activity in an open field.
Results Intra-NAcb core quinpirole increased premature
responding in HI rats but not in LI rats. In contrast, intra-
NAcb shell quinpirole strongly increased locomotor activity
in HI rats, unlike LI rats. This effect was blocked by intra-
NAcb shell infusions of the D2/3 receptor antagonist nafado-
tride (0.03 μg). However, nafadotride was ineffective in
blocking the effects of intra-NAcb core quinpirole on pre-
mature responding in HI rats.
Conclusions These findings indicate that impulsivity and
hyperactivity are separately regulated by core and shell
sub-regions of the NAcb and that HI rats show an enhanced
response to D2/3 receptor activation in these regions. These
results suggest that the symptom clusters of hyperactivity
and impulsivity in attention-deficit hyperactivity disorder
may be neurally dissociable at the level of the NAcb.
Keywords Impulsivity . Locomotion . Quinpirole .
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Introduction
A number of psychopathological disorders including
obsessive-compulsive disorder (OCD), attention-deficit hy-
peractivity disorder (ADHD), schizophrenia and drug abuse
are associated with high levels of impulsivity (American
Psychiatric Association 2000).
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Preclinical and clinical studies demonstrate that high
impulsivity and its related psychopathological disorders in-
volve a dysregulation of the brain dopamine (DA) systems
(Dalley et al. 2011; Fineberg et al. 2010; Volkow et al.
2009).
Trait-like impulsivity in rats, as defined by spontaneously
high levels of anticipatory responses made on a sustained
visual attention test, the five-choice serial reaction time task
(5-CSRTT) (Dalley et al. 2007; Robinson et al. 2009),
predicts increased vulnerability to the reinforcing effects of
psychostimulant drugs that target the mesolimbic DA sys-
tem. High impulsive (HI) rats show greater escalation of
cocaine and nicotine self-administration (Dalley et al. 2007;
Diergaarde et al. 2008), and an increased propensity to
develop compulsive cocaine-seeking and relapse compared
with low impulsive (LI) rats (Belin et al. 2008; Economidou
et al. 2009). Since HI rats exhibit a reduced availability of
D2/3 receptors in the ventral striatum, including the nucleus
accumbens (NAcb), D2/3 receptor dysfunction in the NAcb
may be a marker of individual vulnerability to drug addic-
tion (Dalley et al. 2011).
However, the decrease in D2/3 receptor availability in the
ventral striatum of HI rats could involve changes in one or
more of the functionally distinct sub-regions of the NAcb,
the NAcb core (NAcbC) and the NAcb shell (NAcbS).
Previous research has strongly implicated the NAcbC and
NAcbS in impulsivity, potentially operating in a functional-
ly opposed manner (Besson et al. 2010; Economidou et al.
2012; Sesia et al. 2008). The NAcbC plays a significant role
in regulating response inhibition on the 5-CSRTT (Basar et
al. 2010; Dalley et al. 2011), as well as delay-discounting
impulsivity (Cardinal et al. 2001). Increments in impulsive
responding on the 5-CSRTT induced by systemic adminis-
tration of D-amphetamine depend on D2-like receptors in the
NAcbC, and to a somewhat lesser extent the NAcbS (Pattij
et al. 2007). Moreover, lesions of the NAcbC potentiate,
whereas lesions of NAcbS attenuate, the effect of D-amphet-
amine to increase premature responding in the 5-CSRTT
(Murphy et al. 2008). Consistent with these effects, deep
brain stimulation of the NAcbC and NAcbS produces
strongly opposing effects on impulsivity on the 5-CSRTT
(Sesia et al. 2008) while nafadotride, a D3-preferring antag-
onist (Sautel et al. 1995), increases impulsivity in HI rats
when infused in the NAcbS but decreases impulsivity when
infused in the NAcbC (Besson et al. 2010).
In the present study, we sought to investigate the neural
locus of D2/3 receptor dysfunction in the NAcb of impulsive
rats on the 5-CSRTT. This was achieved by microinjecting
the full D2/3 receptor agonist quinpirole directly into the
NAcbS and NAcbC of LI and HI rats prior to behavioural
performance on the 5-CSRTT. As a control behavioural
procedure we also assessed spontaneous locomotor activity,
which has been shown to depend on D2-like receptors in the
NAcbS (Swanson et al. 1997). The comparison of impul-
sivity and hyperactivity is also important in the modelling of
ADHD as these behaviours have been linked in a common,




The subjects were 96 male Lister-hooded rats (Charles
River, UK), housed in groups of four under temperature-
controlled conditions and a 12:12-h light–dark cycle (lights
off at 0700 h). Rats weighing approximately 250 g at the
start of training were maintained at 85 % of their free-
feeding weight by restricting access to laboratory chow
(Purina, UK) to approximately 18 g/day per rat. Water was
provided ad libitum. All procedures were conducted in
accordance with the requirements of the UK Animals
(Scientific Procedures) Act of 1986.
Apparatus and training
Rats were trained in eight operant 5-CSRTT chambers (25×
25×25 cm), controlled by WhiskerServer (version 2.8) and
FiveChoice client software (version 2.6) (http://www.whisker
control.com), as described previously (Bari et al. 2008;
Robbins 2002). Each daily session consisted of 100 discrete
trials with stable performance being achieved after about 40
sessions. Rats initiated a trial by nose-poking into the maga-
zine. After an inter-trial interval (ITI) of 5 s, a light at the rear
of one of the apertures was presented randomly in one of the
five apertures for a duration of 0.5 s. Responses in this
aperture within a limited illumination period (the limited hold
period) were recorded as correct responses and were rewarded
by the delivery of a food pellet into the magazine (Noyes
45 mg dustless reward pellets, Sandown Scientific Ltd, UK).
Responses in a non-illuminated hole (an ‘incorrect’ response),
a failure to respond within the 5 s limited hold period (an
‘omission’) and responses in one of the apertures during the
ITI (a ‘premature’ response) were also recorded and signalled
by a time-out period where the house-light was switched off
for 5 s. The stimulus duration was 30 s in the initial training
sessions and was progressively reduced to the final duration
used for testing (0.5 s), depending on the rats individual
performance. Rats reached the criterion of stable pre-
operative performance when they achieved ≥80 % accuracy
with fewer than 20 % omissions. An average of 40 daily
sessions, each consisting of approximately 100 trials and
lasting 30 min was required to reach this criterion.
Following acquisition of the 5-CSRTT, rats were
screened for impulsivity over a 3-week period using the
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same procedure as described previously (Dalley et al. 2007).
Animals were first tested on two consecutive days using a
stimulus duration of 0.5 s and an ITI of 5 s. On day 3,
animals were challenged with a long ITI where the delay
from trial onset to stimulus presentation was increased to
7 s, a manipulation that increases the frequency of prema-
ture responses and which helps to differentiate between high
and low impulsive rats on the 5-CSRTT (Dalley et al. 2007).
On days 4 and 5, animals were re-tested with a stimulus
duration of 0.5 s and an ITI of 5 s. This cycle of short and
long ITI testing was repeated on two further occasions. The
criterion for selecting HI rats was a mean level of premature
responses greater than or equal to 50 on each of the long ITI
sessions. The frequency of HI rats in different batches of
Lister hooded rats is remarkably stable and varies between
8 and 14 %. Rats were trained in two squads, each compris-
ing 48 rats. LI rats were selected from the two squads as the
lowest ranked animals in terms of mean premature
responses during the three long ITI sessions. This screening
procedure yielded 11 HI rats and 10 LI rats, which were
each then subdivided into two groups for the subsequent
intra-NAcbS and intra-NAcbC infusion experiments.
Surgery
Subjects were anesthetised with ketamine (Ketaset,
100 mg/kg, intraperitoneally (i.p.); Vet Drug, Bury St
Edmunds, UK) and xylazine (Rompun, 10 mg/kg, i.p. Vet
Drug), and secured in a stereotaxic frame with the incisor
bar set at −3.3 mm relative to the intraural line in a flat skull
position. Bilateral 22-gauge double-guide cannulae (Plastic
One, Sevenoaks, UK) were bilaterally implanted above either
the NAcbC or the NAcbS, according to the following stereo-
taxic anterior–posterior (AP), mediolateral (ML) and dorso-
ventral (DV) coordinates NAcbC: AP +1.7 mm, ML ±1.9
mm, DV −2.2 mm; NAcbS: AP +1.7 mm, ML ±0.75 mm,
DV −2.0 mm. AP and ML coordinates were taken from
bregma, DV coordinates from skull surface (Paxinos and
Watson, 1998). Cannulae were secured to the skull with dental
acrylic and stainless steel screws, and a wire stylet occluded
the guide to maintain patency. After surgery, animals were
housed individually and allowed 5–7 days recovery.
Intracerebral drug administration
For all experiments, drugs were administered according to a
fully randomised Latin-square design and separated by a
minimum of 72 h between drug challenge sessions.
Experiments were separated by a 1-week washout period.
Quinpirole hydrochloride (Sigma Chemical, St. Louis, MO,
USA) was prepared in 0.9 % NaCl. Nafadotride (Tocris
Cookson, Bristol, UK) was dissolved in 1 M HCl and
0.9 % NaCl. The final pH was adjusted to approximately 6
using 0.1 M NaOH. Drug solutions were frozen at −80 °C
prior to use.
Rats received two habituation sessions to the microinfu-
sion procedure. During the first habituation session, the
injector was inserted through the guide cannula and left in
place for 1 min. In the second habituation session, rats
received one control vehicle infusion (0.9 % NaCl). Here,
rats were gently restrained while the stylets were removed.
Twenty-eight gauge bilateral injectors (Plastics One,
Sevenoaks, UK), extending 4.5 mm (NAcbC) or 5 mm
(NAcbS) beyond the length of the guide cannulae, were left
in place for 1 min before each infusion (0.5 μl infused over
1 min). Injectors were left in place for 1 min to allow for
diffusion of the drug into the surrounding tissue. The injec-
tor was then removed and the stylet replaced. Infusion
studies were run in 3-day cycles, starting with a baseline
session on day 1. On the following day, rats received a drug
or vehicle infusion, 5 min before testing in the 5-CSRTT or
the photocell activity cages. On the third day, animals were
not tested and remained in their home cage.
Locomotor activity assessment
HI and LI rats were tested in Plexiglas activity cages (mea-
suring 39×39×15 cm), equipped with photocell beams
interfaced to a microcomputer (San Diego Instruments,
US). Over two consecutive days, animals were habituated
to the activity cages before the beginning of the infusion
experiment. Animals were also habituated to the microinfu-
sion procedure in the activity cages. During each test ses-
sion, and following a 30-min period of habituation to the test
cages, rats received drug infusions into either the NAcbC or
NAcbS, before being returned to the activity cages.
Locomotor activity was measured as the number of photo-
cell beam breaks over a 30-min period following each drug
infusion.
Experimental design
The behavioural effects of quinpirole were tested in LI and
HI rats following its administration into either the NAcbC or
the NAcbS, and also following the administration of the
D2/3 receptor antagonist nafadotride.
Experiment 1: Performance on the 5-CSRTT
following quinpirole administration in the NAcbC or NAcbS
Rats received infusions of vehicle or quinpirole (0.1, 0.3 or
1 μg per side) into the NAcbC or NAcbS, and were placed
in the 5-CSRTT chamber. Doses of quinpirole were chosen
on the basis of previous experiments in our laboratory
shown to be pharmacologically active in this region (Pezze
et al. 2007).
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Experiment 2: Effects of intra-NAcb quinpirole
on locomotor activity
Rats received infusions of vehicle or quinpirole (0.1, 0.3 or
1 μg per side) into the NAcbC or NAcbS, and were placed
in the activity cages. The doses of quinpirole were chosen
based on a pilot study and on previous studies (Gong et al.
1999; Swanson et al. 1997).
Experiment 3: Effects of intra-NAcbC nafadotride
on quinpirole-induced impulsivity on the 5-CSRTT
Rats received a vehicle infusion (0.01 M phosphate-buffered
saline, PBS) or nafadotride (0.03 μg per side) into the
NAcbC, followed 3 min later by a second infusion of
vehicle or quinpirole (1 μg per side). Rats were tested with
an ITI of 5 s. One HI rat was removed from the study due to
unstable performance. The doses of quinpirole and nafado-
tride were chosen according to the results of experiments 1
and 2, as well as a previous study (Besson et al. 2010).
Experiment 4: Effects of intra-NAcbS nafadotride
on quinpirole-induced locomotor activity
Rats received one infusion of vehicle or nafadotride
(0.03 μg per side) into the NAcbS, and then 3 min later a
second infusion of vehicle or quinpirole (1 μg per side),
before being placed in the activity cages. The doses of
quinpirole and nafadotride were chosen according to the
results in experiments 1 and 2, and previous studies (Barik
and Beaurepaire 1996; Canales and Iversen 2000).
Histological assessment
Following the completion of the experiments, subjects were
anesthetised with a lethal dose of sodium pentobarbitone
(1.5 ml per rat, i.p., Dolethal 200 mg/ml, Rhone-Merieux,
Athens, USA) and perfused transcardially with 0.01 M PBS
followed by 4 % paraformaldehyde. Brains were removed
and postfixed in paraformaldehyde. Prior to being cut, the
brains were transferred to 20 % sucrose in 0.2 M PBS and
left overnight. Coronal sections were cut at 60 μm on a
freezing microtome and stained with Cresyl Violet.
Cannulae locations were verified under a light microscope
and mapped onto standardised coronal sections of a rat brain
stereotaxic atlas (Paxinos and Watson 1998).
Data analysis
Impulsivity screening
Behavioural data were analyzed using two-way repeated-
measures analysis of variance (ANOVA), with one within
subject’s factor “session” (11 levels) and one between sub-
ject’s factor “group” (HI, LI). Experiments 1 and 2: The
effects of intra-NAcb infusions of quinpirole on 5-CSRTT
performance and locomotor activity in HI and LI rats were
analysed by three-way repeated measures ANOVA, with
one within subject’s factor “group” (HI, LI) and two be-
tween subject’s factors “NAcb sub-region” (core, shell) and
“drug” (saline, 0.1, 0.3 or 1 μg). The data were further
analysed with a two-way repeated-measures ANOVA with
factors “NAcb sub-region” and “drug”. Experiments 3 and
4: The effects of co-administered nafadotride and quinpirole
were analysed using a three-way repeated measures
ANOVA with within-subject’s factors “quinpirole” (saline,
1 μg) and “nafadotride” (vehicle, 0.03 μg) and one between
subject’s factor “group” (HI, LI). Homogeneity of variance
was confirmed by Levene’s test. Post-hoc comparisons were
made using a Duncan’s t test. We also performed non-
parametric analyses using Friedman’s ANOVA. Post-hoc
comparisons were made using Wilcoxon signed-rank (for
unrelated samples) and Mann–Whitney sum-rank (for relat-
ed samples) tests. All tests were evaluated against two-tailed
probabilities. As the non-parametric tests did not alter the
main conclusions of this study only parametric statistics are
reported. Statistical significance was set at p<0.05.
Results
Characterisation of high impulsivity on the 5-CSRTT
Figure 1 and Supplementary Table 1 shows the profile of
behaviour of LI and HI rats on the 5-CSRTT. HI rats made
more premature responses compared with LI rats (group:
F1,19=64.6, p<.0001; session: F10,190=56.2, p<.0001;
group × session: F10,190=14.3, p<.0001). The increase in
premature responding observed on days 1, 6 and 11
Fig. 1 Screening for impulsivity on the 5-CSRTT. Shown are levels of
impulsivity, expressed as a percentage of premature responses, during
baseline sessions (ITI = 5 s; sessions 2–5, 7–10) and long ITI sessions
(LITI = 7 s; sessions 1, 6 and 11) in HI and LI rats. ***p≤0.0001
indicate significant differences vs LI on LITI sessions
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coincided with the three challenge sessions (ITI of 7 s) used
to screen for impulsivity. Post hoc analyses revealed that in
the HI group, the challenge sessions produced a greater
increase in premature responses on the 3 days tested (p<
0.01) compared to LI rats (Fig. 1). No significant differences
were found between HI and LI on accuracy, omissions,
perseveration, as well as correct and magazine response
latencies (see Supplementary Table 1).
Figure 2 shows the positions of the injector tips in the
NAcbC and NAcbS. In total, two rats were excluded from
the study (one HI and one LI) because injector cannulae
were positioned outside of the intended target areas. There
was no gross tissue damage in the local vicinity of the
injector tracks.
Experiment 1: Effects of intra-NAcbC and intra-NAcbS
quinpirole on 5-CSRTT performance
Figure 3 and Table 1 shows the effects of intra-NAcb quin-
pirole on premature responding and other behavioural meas-
ures on the 5-CSRTT. Quinpirole significantly increased
impulsive responding in HI rats compared to LI rats (group ×
drug: F3,45=6.2, p<0.01; group: F1,15=33.3, p<0.001; drug:
F3,45=8.9, p<0.001). Divergent effects of quinpirole effects
in HI and LI were also revealed by trend significant
group × drug × NAcb sub-region interaction (F3,45=2.3,
p=0.09) and a significant group × NAcb sub-region interac-
tion (F1,15=7.5, p<0.05; NAcb sub-region: F1,15=6.3, p<
0.05). Further analyses confirmed that in HI rats (Fig. 3a),
quinpirole significantly increased impulsive responding, an
effect that was dependent on NAcb sub-region (drug ×
NAcb sub-region: F3,24=2.9, p<0.05; drug: F3,24=9.1,
p<0.001). Post hoc analyses revealed that quinpirole signifi-
cantly enhanced impulsive responding when infused into the
NAcbC at the following doses: 0.1 μg (p=0.06), 0.3 μg
(p<0.001) and 1 μg (p<0.001) versus saline; and at 0.3 μg
(p<0.01) and 1μg (p<0.001) relative to same doses infused in
the NAcbS. In contrast, quinpirole had no significant effect on
premature responding in LI rats (Fig. 3b). There were no
significant effects of intra-NAcbC or NAcbS quinpirole on
accuracy, omissions, perseveration, correct response latencies
and magazine latencies (see Table 1).
Experiment 2: Effects of intra-NAcbC and intra-NAcbS
quinpirole on locomotor activity
Figure 4 shows the effects of intra-NAcb quinpirole on
locomotor activity. Quinpirole produced a significant in-
crease in locomotor activity with differential effects in HI
and LI rats (group × drug × NAcb sub-region interaction:
F3,45=3.2, p<0.05; drug: F3,45=19.1, p<0.001; NAcb sub-
region: F1,15=4.4, p<0.05; group: F1,15=0.1, p=0.4).
Further analyses confirmed that in HI rats (Fig. 4a), quinpir-
ole significantly increased locomotor activity only when
infused into the NAcbS sub-region (drug × NAcb sub-
region interaction: F3,24=5.9, p<0.01). Post hoc analyses
revealed that quinpirole produced a dose-dependent increase
in locomotor activity when infused into the NAcbS, at doses
Fig. 2 Schematic
representations of the ventral-
most position of injector tips
in the NAcb shell (a) (n=9)
and NAcb core (b) (n=10).
Drawing adapted from Paxinos
and Watson (1998)
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0.3 μg (p<0.05) and 1 μg (p<0.001) vs saline control
group; and at 0.3 μg (p=0.06) and 1 μg (p<0.001) com-
pared to the same doses in the NAcbC. Thus, intra-NAcbC
quinpirole had no significant effect on locomotor activity in
HI rats. However, in the LI rats (Fig. 4b), quinpirole in-
creased locomotor activity when infused in the NAcbC and
the NAcbS (drug effect: F3,21=13.0, p<0.01). Post hoc
analyses revealed that quinpirole significantly increased loco-
motor activity at the doses of 0.3 μg (p<0.05) and 1 μg (p<
0.0001) relative to the saline group.
Experiment 3: Effect of intra-NAcbC nafadotride
on quinpirole-induced impulsivity
Figure 5 and Table 2 shows the effects of the intra-NAcbC
infusions of nafadotride in combination with quinpirole on
impulsive responding and other behavioural measures on
the 5-CSRTT. Quinpirole significantly increased impulsive
responding in HI rats compared to LI rats (group × drug:
F1,6=4.0, p<0.05). In the HI group (Fig. 5a), nafadotride
(0.03 μg) had no significant effect on premature responding,
Fig. 3 Effects of microinfusions of the D2/3 receptor agonist quinpir-
ole (0.1, 0.3 or 1 μg per side) into the NAcbC (grey bars) and NAcbS
(white bars) of HI (a) and LI (b) rats on the 5-CSRTT. Final group
sizes: NAcbC (HI n=5, LI n=5); NAcbS (HI n=5, LI n=4). Doses are
expressed as micrograms per 0.5 μl. Data are means ± SEM. ***p≤0.001
indicate significant differences vs saline infusion. #p≤0.01 significant
differences vs same dose in NAcbS
Table 1 Effects of microinfusions of the D2/3 receptor agonist quinpirole (0.1, 0.3 or 1 μg per side) into the NAcbC and NAcbS of HI and LI rats
on the 5-CSRTT
Group NAcb subregion Sal 0.1 μg 0.3 μg 1 μg
Accuracy (%) HI Shell 87.8±1.6 80.6±4.2 85.2±2.4 81.9±5.0
Core 88.9±3.4 84.1±3.2 83.2±2.5 83.2±3.1
LI Shell 87.3±6.1 86.9±3.2 86.3±3.8 87.4±2.8
Core 90.1±2.6 88.3±2.6 90.4±2.2 88.9±2.0
Omission (%) HI Shell 4.2±0.9 6.4±2.3 3.4±1.0 8.2±2.5
Core 5.0±1.3 6.4±2.2 4.4±1.0 6.2±1.5
LI Shell 4.5±1.0 1.8±1.0 1.8±0.2 5.8±1.9
Core 8.2±1.2 3.8±1.4 5.0±1.4 7.6±3.3
Perseveration HI Shell 39.6±5.90 50.4±8.10 46.0±6.4 63.2±10.5
Core 64.4±11.5 65.6±13.9 66.8±14.0 61.2±11.5
LI Shell 56.3±12.0 38.8±13.9 45.3±19.9 50.5±22.4
Core 60.4±13.0 51.2±12.0 58.2±16.5 61.2±27.4
Correct response latency (s) HI Shell 0.55±0.03 0.56±0.05 0.46±0.01 0.51±0.03
Core 0.63±0.14 0.48±0.04 0.52±0.04 0.49±0.02
LI Shell 0.48±0.03 0.56±0.07 0.47±0.02 0.52±0.05
Core 0.51±0.02 0.52±0.03 0.51±0.04 0.50±0.01
Magazine latency (s) HI Shell 1.69±0.11 1.68±0.22 1.59±0.15 2.19±0.69
Core 1.50±0.11 1.33±0.10 1.38±0.97 1.48±0.11
LI Shell 2.33±0.57 2.41±0.69 1.61±0.38 1.87±0.27
Core 1.95±0.38 3.06±1.45 1.61±0.13 1.55±0.17
Final group sizes: NAcbC (HI n=5, LI n=5); NAcbS (HI n=5, LI n=4). Doses are expressed as micrograms per 0.5 μl. Data are means ± SEM
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and did not block the enhancing effects of quinpirole on
premature responding when infused into NAcbC (quinpirole
effect: F1,4=10.9, p<0.05). In the LI group (Fig. 5b), neither
nafadotride nor quinpirole had any significant effect on
premature responding.
Experiment 4: Effect of intra-NAcbS nafadotride
on quinpirole-induced locomotor activity
Figure 6 shows the effects of the intra-NAcbS infusions of
nafadotride in combination with quinpirole on locomotor
activity. Nafadotride produced differential effects in HI
and LI (group × nafadotride × quinpirole effect: F1,7=6.7,
p<0.05). In the HI group (Fig. 6a), nafadotride blocked
quinpirole-induced locomotor activity (quinpirole × nafado-
tride interaction: F1,4=8.5, p<0.05). Post hoc tests
revealed that intra-NAcbS quinpirole increased locomo-
tor activity (p<0.01) vs saline; this effect was blocked
when quinpirole was combined with nafadotride (p<0.01,
vs the vehicle-quinpirole group). In the LI group (Fig. 6b),
quinpirole increased locomotor activity (quinpirole effect:
F1,3 =58.9, p<0.01); this effect was not blocked by
nafadotride.
Discussion
The present study investigated D2/3 receptor function in the
core and shell sub-regions of the NAcb associated with the
presumed trait of high impulsivity in rats (Dalley et al.
2007). The main findings indicate a striking neuroanatomi-
cal dissociation in the effects of the D2/3 receptor agonist
quinpirole on impulsive responding in the 5-CSRTT and
locomotor activity in low- and high-impulsive rats. We
found that, while quinpirole exacerbated impulsivity in HI
rats when infused in the NAcbC, it had no effect on impul-
sivity when infused in the NAcbS, nor did it affect impul-
sivity in LI rats when administered into the NAcbC or
NAcbS. Conversely, quinpirole produced locomotor hyper-
activity in both HI and LI rats when infused into the NAcbS
but only in LI rats when infused into the NAcbC. The
stimulatory effect of quinpirole on locomotor activity how-
ever was greater in HI rats than LI rats. Overall, the double
dissociation of behavioural effects according to NAcb sub-
regions indicates considerable specificity of function within
the NAcb and related structures, consistent with other recent
evidence (e.g. Goto and Grace 2005; Reynolds and Berridge
2008). The pattern of findings also suggests that the effects
Fig. 4 Effects of microinfusions of quinpirole (0.1, 0.3 or 1 μg per
side) into the NAcbC (grey bars) and NAcbS (white bars) of HI (a) and
LI (b) rats on locomotor activity. Final group sizes: NAcbC (HI n=5, LI
n=5); NAcbS (HI n=5, LI n=4). Doses are expressed as micrograms per
0.5 μl. Data are means ± SEM. *p≤0.05 and ***p≤0.001 indicate
significant differences vs saline infusion. #p≤0.001 significant differ-
ences vs same dose in NAcbS
Fig. 5 Effects of intra-NAcbC
infusions of the D3 receptor
antagonist nafadotride (0.03 μg
per side) on quinipirole-induced
impulsivity on the 5-CSRTT
(1 μg per side) in a HI rats
(n=5) and b LI rats (n=4).
Doses are expressed as
micrograms per 0.5 μl. Data
are means ± SEM. *p≤0.05
indicate significant differences
vs saline infusion
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of centrally infused quinpirole were quite well localised and
unlikely to have arisen from diffusion to distal anatomical
sites.
Our findings indicate that HI rats show an increased
sensitivity to local D2/3 receptor stimulation in the NAcb,
expressed as either hyperactivity or impulsivity depending
on the precise sub-region of the NAcb affected. The results
are not only important in revealing likely D2/3 receptor
dysfunction in HI rats but also in demonstrating apparently
independent neuroanatomical substrates for two key symp-
toms of ADHD at the level of the NAcb sub-regions, hy-
peractivity and impulsivity. The functional significance of
this behavioural dissociation presumably arises from a con-
sideration of the predominant anatomical projections to the
core and shell, from in particular, medial prefrontal and hip-
pocampal sources (Goto and Grace 2005). Hypothetically,
these projections respectively govern cognitive control over
those response preparatory processes that are impaired in HI
rats in the 5-CSRTT, as well as locomotor exploratory
responses to the environmental context.
Neural basis of impulsivity
The present data add to accumulating evidence that impul-
sive responding on the 5-CSRTT is mediated by the NAcb
(Basar et al. 2010; Cole and Robbins 1989) probably via the
core sub-region (Pattij et al. 2007). Thus the latter authors
found that impulsive responding on the 5-CSRTT produced
by D-amphetamine was blocked by intra-NAcbC infusion of
the D2/3 receptor antagonists eticlopride or sulpiride. A
similar blockade has been found following the induction
of premature responses by lesions of the prefrontal cortex
(Pezze et al. 2009). The relative lack of effect of quinpirole
in LI rats is consistent with the evidence of Pezze et al.
(2007) who similarly found that quinpirole did not increase
premature responses in the 5-CSRTT.
Effects of nafadotride on hyperactivity and impulsivity
Intra-NAcb shell infusions of the D3-preferring antagonist
nafadotride blocked the effects of quinpirole on locomotor
activity in HI rats but had no effect on increased impulsivity
induced by local administration of quinpirole in the NAcbC.
These findings are consistent with receptor binding studies
that have highlighted the important role of D3 receptors in
the NAcbS, with relatively higher densities of D3 than D2
receptors as compared to the core sub-region (Bardo and
Hammer 1991; Diaz et al. 1995, 2000). Although, the
effects of other D3 receptor antagonists on motor function
are still controversial (Millan et al. 2000, 2004; Reavill et al.
Table 2 Effects of intra-NAcbC
infusions of the D3 receptor
antagonist nafadotride
(0.03 μg per side) combined
with quinipirole on the
5-CSRTT (1 μg per side) in HI
rats (n=5) and LI rats (n=4)
Doses are expressed as micro-
grams per 0.5 μl. Data are
means ± SEM
Group Sal + Veh N + Sal Veh + Qui Naf + Qui
Accuracy (%) HI 74.3±6.2 77.8±3.0 71.8±8.7 79.0±3.0
LI 82.9±3.9 85.1±5.9 84.4±4.5 74.2±2.5
Omission (%) HI 8.4±3.1 4.3±0.8 9.5±3.1 4.6±2.0
LI 8.7±2.8 2.75±1.4 4.5±1.0 10.7±6.7
Perseveration HI 113.8±15.5 84.4±12.5 65.6±16.6 98.6±15.7
LI 72.7±8.6 58.7±15.8 79.5±9.7 70.7±20.6
Correct response latency (s) HI 0.63±0.13 0.61±0.05 0.73±0.23 0.67±0.10
LI 0.57±0.01 0.57±0.07 0.54±0.03 0.62±0.06
Magazine latency (s) HI 1.69±0.15 1.61±0.06 2.46±0.77 1.81±0.08
LI 1.46±0.19 1.75±0.52 1.57±0.16 1.96±0.46
Fig. 6 Effects of intra-NAcbS
infusions of the D3 receptor
antagonist nafadotride (0.03 μg
per side) on quinpirole-induced
locomotor activity (1.0 μg per
side) in a HI rats (n=5) and b LI
rats (n=4). Doses are expressed
as micrograms per 0.5 μl. Data
are means ± SEM. **p≤0.01
indicate significant differences
vs saline infusion. #p≤0.05
significant differences vs
vehicle-quinpirole infusion
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2000), previous studies have shown that intra-NAcb nafa-
dotride, a preferential D3 receptor antagonist, blocks hyper-
activity induced by DA receptor agonists (Canales and
Iversen 2000), supporting the role of D3 receptors in the
NAcb on hyperactivity.
In contrast, intra-NAcbC infusions of nafadotride were
ineffective in blocking quinpirole-induced impulsive
responding on the 5-CSRTT in HI rats. A previous study
from our laboratory did show a reduction in impulsive
responding by a higher dose of nafadotride (0.1 μg) into
NAcbC, but the same dose as used in the present study
(0.03 μg) did not affect impulsive responding on the 5-
CSRTT in HI rats (Besson et al. 2010). Although nafado-
tride has been shown to be a preferential antagonist of D3
receptors, possible actions at D2 receptors cannot be dis-
counted, especially at higher doses (Flietstra and Levant
1998). Therefore, the lack of effect of intra-NAcbC nafado-
tride on impulsivity in HI rats suggests that the effects of
quinpirole on impulsivity in this region may be mediated by
D2 receptors. Indeed, it has been previously been demon-
strated that amphetamine-induced impulsivity is more effec-
tively blocked by D2 receptor antagonists than selective D3
receptor antagonists (van Gaalen et al. 2009). In addition to
finding reductions in impulsive responding following high
doses of intra-core nafadotride, Besson et al. (2010) reported
an increase in impulsivity when nafadotride was infused in
the NAcbS of HI rats—supporting (1) the hypothesis that
D2/3 receptors in the core mediate impulsive behaviour, and
(2) a possible ‘opponent’ effect on impulsivity of DA acting
at D3 receptors in the shell sub-region.
Differential effects of quinpirole in low- and high-impulsive
rats
Previously, it was found that systemic quinpirole dose-
dependently and selectively reduced impulsive responding
in HI rats on the 5-CSRTT (Fernando et al. 2012), whereas
the present results following central administration show
only dose-dependent increases in responding. It would
therefore appear likely that the site of the impulsivity-
reducing effects is not in the NAcb, other obvious sites
possibly including the ventral tegmental area, dorsal stria-
tum or prefrontal cortex. Indeed, infusion of quinpirole into
the orbitofrontal cortex of HI rats has been shown to de-
crease premature responding on the 5-CSRTT, but it also
affected other performance parameters such as a reduction on
accuracy, increased omissions and latencies to respond, sug-
gesting more general, non-specific actions at this site
(Winstanley et al. 2010).
We previously reported that impulsivity in rats is inverse-
ly related to the availability of D2/3 receptors in the ventral
striatum, including the NAcb (Dalley et al. 2007). The
present study was partly motivated by the relatively poor
spatial resolution of positron emission tomography used in
our earlier study, which was unable to localise changes in
D2/3 receptors to the principal sub-regions of the NAcb. We
hypothesised that HI rats would show altered behavioural
responses to a D2/3 receptor agonist locally administered in
the NAcb core and shell. In fact, impulsivity was exacerbat-
ed in HI rats when quinpirole was locally administered in
the NAcbC and HI rats were also more hyperactive than LI
rats when quinpirole was administered in the NAcbS. These
results thus indicate an important neural dissociation in the
modulation of hyperactivity and impulsivity across the two
sub-divisions of the NAcb, possibly differentially dependent
on D2 and D3 receptors. They are consistent with other
recent findings of an apparent opponent modulation of these
behaviours by DA and noradrenergic mechanisms between
the NAcb sub-regions (Economidou et al. 2012).
Furthermore, the results suggest that increased DA trans-
mission in the NAcbC is sufficient to increase impulsivity
on the 5-CSRTT but only in animals showing spontaneously
high levels of impulsive behaviour. These effects were behav-
iourally selective, with no effects for example, on other
parameters of 5-CSRTT performance, including attentional
accuracy.
A putative mechanism to account for such behavioural
hyper-responsiveness, in the absence of any strong evidence
of presynaptic DA dysfunction in HI rats (Dalley et al.
2007), would be post-synaptic receptor supersensitivity.
However, this is inconsistent with the evidence of reduced
D2/3 receptor number, as measured with PET (Dalley et al.
2007) unless there are differential contributions from D2 and
D3 receptors. An alternative mechanism potentially involves
the disinhibition of the NAcbS via D2/3 receptor-mediated
inhibition of medium spiny GABA-ergic neurons in the
NAcbC (Mizuno et al. 2007). This hypothesis is supported
by evidence that dopamine inputs to the core and shell
operate in a functionally opposed manner to regulate impul-
sivity (Besson et al. 2010; Diergaarde et al. 2008; Sesia et al.
2008) and that selective lesions of the NAcbC augment the
effects of stimulant drugs on impulsivity in the 5-CSRTT
(Murphy et al. 2008). Thus, the more pronounced effect of
intra-NAcbC quinpirole on impulsivity in HI rats suggests
the presence of underlying abnormalities in the NAcbS of
these animals. Consistent with this notion D2/3 receptors are
significantly decreased in the NAcbS, but not NAcbC of HI
rats compared with LI rats (Jupp et al. 2013). However, the
precise mechanism underlying the control of NAcbS activity
and output by dopamine receptors in the NAcbC of hyper-
impulsive animals will require further investigation.
Neural basis of locomotor hyperactivity
While there is evidence of mediation by both the NAcbC as
well as the NAcbS in the modulation of locomotor
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hyperactivity by D2/3 agents (Dreher and Jackson 1989;
Gong et al. 1999; Phillips et al. 1995; Plaznick et al.
1989), the NAcbS has been shown to be preferentially
implicated (Heidbreder and Feldon 1998; Swanson et al.
1997). In the present study, HI and LI rats, selected accord-
ing to their impulsivity response in the 5-CSRTT, but with
no differences in spontaneous locomotor activity (Molander
et al. 2011) exhibited differential locomotor responses fol-
lowing intra NAcbC vs NAcbS quinpirole infusions. Intra-
NAcbS quinpirole infusions enhanced locomotor activity in
HI rats compared with both the effects of NAcb core infu-
sions and with effects in LI rats. The enhanced response by
quinpirole infusion into NAcbS of HI rats is in accordance
with the results obtained in another selected strain of rats,
the Roman high avoidance rats (RHA), which also exhibits
high impulsivity as measured using the 5-CSRTT (Moreno
et al. 2010). The RHA rats showed a larger increase in DA
efflux in the NAcbS compared to the core following acute
administration of stimulants such as cocaine and D-amphet-
amine compared to the Roman low avoidance strain and in
accordance with their enhanced locomotor response (Lecca
et al. 2004). These findings are consistent with evidence that
dopamine release is increased in the NAcbS of HI rats in the
5-CSRTT (Diergaarde et al. 2008), an effect that may be
driven by decreased presynaptic D2/3 receptors in this region
(Jupp et al. 2013).
Psychopathological implications
The greater sensitivity of HI rats to the locomotor effects of
D2/3 agonists infused into NAcbS is consistent with the
enhanced self-administration of cocaine and nicotine in
these animals, as well as in RHA rats (Dalley et al. 2007;
Diergaarde et al. 2008; Fattore et al. 2009; Giorgi et al.
2007); and substantial evidence that DA-ergic projections
to the NAcbS mediate the reinforcing properties of psychos-
timulants (Bardo 1998; Heidbreder et al. 2005; Wise 1998;
for review Di Chiara 2002).
The present study also suggests that the behavioural
responses of impulsivity and locomotion to D2/3 stimulation
in the NAcb may be differentiated according to the site of
action, DA receptor modulation and impulsivity trait.
Whereas the shell sub-region in the HI rats is hypothetically
relatively more sensitive to the locomotor effects of activa-
tion of D3 receptors, the core sub-region in the HI is more
sensitive to impulsivity resulting from D2 receptor activa-
tion by quinpirole infusion. Moreover, infusion of the selec-
tive D3 receptor antagonist nafadotride into the NAcbS,
reduced the quinpirole-induced locomotor response in HI
rats, but was ineffective in blocking the quinpirole-induced
increase in impulsive responding in the NAcbC. These
results support previous evidence that D2/3 receptor dys-
function and disrupted control between the NAcb sub-
regions leads to impulsive behaviour. As well as contribut-
ing to an understanding of the neurobiological mechanisms
underlying impulsive traits possibly relevant to drug abuse
(Dalley et al. 2011) and schizophrenia (Natesan et al. 2011),
the present findings indicate possible mechanisms by which
hyperactivity and impulsivity may be manifested as distinct
symptoms in ADHD, modulated by D2/3 receptors in the
nucleus accumbens.
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